Patient Identification, Selection, and Timing of Antimicrobial Treatment in the Context of Year 2020 ERS/ATS/ESCMID/IDSA Guideline-Based Therapy for MAC Lung Disease

Patient Identification, Selection, and Timing of Antimicrobial Treatment in the Context of Year 2020 ERS/ATS/ESCMID/IDSA Guideline-Based Therapy for MAC Lung Disease


Published

August 27, 2021

Created by

CMEducation Resources symposium

Related Presenters

Christoph Lange, MD

Christoph Lange, MD

Medical Director/Clinical Director
Research Center Borstel
Borstel, Germany